Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $11.08 million. The enterprise value is $4.24 million.

Market Cap	11.08M
Enterprise Value	4.24M

Important Dates

The last earnings date was Friday, March 13, 2026, before market open.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ACXP has 2.86 million shares outstanding. The number of shares has increased by 85.46% in one year.

Current Share Class	2.55M
Shares Outstanding	2.86M
Shares Change (YoY)	+85.46%
Shares Change (QoQ)	+33.37%
Owned by Insiders (%)	5.05%
Owned by Institutions (%)	9.68%
Float	2.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.23
P/TBV Ratio	2.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.18

Current Ratio	3.18
Quick Ratio	3.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -270.80% and return on invested capital (ROIC) is -171.91%.

Return on Equity (ROE)	-270.80%
Return on Assets (ROA)	-87.59%
Return on Invested Capital (ROIC)	-171.91%
Return on Capital Employed (ROCE)	-153.59%
Weighted Average Cost of Capital (WACC)	-2.12%
Revenue Per Employee	n/a
Profits Per Employee	-$1.99M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.28% in the last 52 weeks. The beta is -1.16, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-1.16
52-Week Price Change	-58.28%
50-Day Moving Average	2.41
200-Day Moving Average	5.08
Relative Strength Index (RSI)	60.60
Average Volume (20 Days)	7,997,438

Short Selling Information

The latest short interest is 57,707, so 2.02% of the outstanding shares have been sold short.

Short Interest	57,707
Short Previous Month	73,787
Short % of Shares Out	2.02%
Short % of Float	2.39%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.09M
Pretax Income	-7.97M
Net Income	-7.97M
EBITDA	n/a
EBIT	-8.09M
Earnings Per Share (EPS)	-$5.32

Balance Sheet

The company has $7.56 million in cash and n/a in debt, with a net cash position of $7.56 million or $2.65 per share.

Cash & Cash Equivalents	7.56M
Total Debt	n/a
Net Cash	7.56M
Net Cash Per Share	$2.65
Equity (Book Value)	5.27M
Book Value Per Share	2.24
Working Capital	5.27M

Cash Flow

Operating Cash Flow	-6.79M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-85.46%
Shareholder Yield	-85.46%
Earnings Yield	-67.56%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $143.67, which is 3,602.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$143.67
Price Target Difference	3,602.84%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 5, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1